Free Trial
→ SpaceX eyes a 1.75 trillion valuation - here's what to know (From Brownstone Research) (Ad)tc pixel Free TRLS Stock Alerts

Trellus Health (TRLS) Competitors

GBX 0.12 0.00 (0.00%)
As of 06/1/2026
Compare

TRLS vs. IQAI, DVRG, SENS, EMIS, and CRW

Should you buy Trellus Health stock or one of its competitors? MarketBeat compares Trellus Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Trellus Health include IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), and Craneware (CRW). These companies are all part of the "health information services" industry.

How does Trellus Health compare to IQ-AI?

IQ-AI (LON:IQAI) and Trellus Health (LON:TRLS) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, media sentiment, analyst recommendations and dividends.

IQ-AI has higher revenue and earnings than Trellus Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IQ-AI£538.19K3.30N/AN/AN/A
Trellus Health£359K1.44-£7.98M-£5.00N/A

IQ-AI has a net margin of -77.52% compared to Trellus Health's net margin of -1,918.66%. Trellus Health's return on equity of -67.29% beat IQ-AI's return on equity.

Company Net Margins Return on Equity Return on Assets
IQ-AI-77.52% -140.75% -22.03%
Trellus Health -1,918.66%-67.29%-22.76%

1.6% of Trellus Health shares are held by institutional investors. 66.0% of IQ-AI shares are held by insiders. Comparatively, 17.0% of Trellus Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

IQ-AI has a beta of 2.25, suggesting that its stock price is 125% more volatile than the broader market. Comparatively, Trellus Health has a beta of 2.509, suggesting that its stock price is 151% more volatile than the broader market.

In the previous week, IQ-AI's average media sentiment score of 0.00 equaled Trellus Health'saverage media sentiment score.

Company Overall Sentiment
IQ-AI Neutral
Trellus Health Neutral

Summary

IQ-AI beats Trellus Health on 5 of the 9 factors compared between the two stocks.

How does Trellus Health compare to DeepVerge?

Trellus Health (LON:TRLS) and DeepVerge (LON:DVRG) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, dividends, valuation and earnings.

In the previous week, Trellus Health's average media sentiment score of 0.00 equaled DeepVerge'saverage media sentiment score.

Company Overall Sentiment
Trellus Health Neutral
DeepVerge Neutral

DeepVerge has a net margin of -19.81% compared to Trellus Health's net margin of -1,918.66%. DeepVerge's return on equity of -10.27% beat Trellus Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Trellus Health-1,918.66% -67.29% -22.76%
DeepVerge -19.81%-10.27%-5.56%

1.6% of Trellus Health shares are held by institutional investors. Comparatively, 4.2% of DeepVerge shares are held by institutional investors. 17.0% of Trellus Health shares are held by insiders. Comparatively, 9.5% of DeepVerge shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Trellus Health has a beta of 2.509, indicating that its share price is 151% more volatile than the broader market. Comparatively, DeepVerge has a beta of 1.07, indicating that its share price is 7% more volatile than the broader market.

DeepVerge has higher revenue and earnings than Trellus Health. Trellus Health is trading at a lower price-to-earnings ratio than DeepVerge, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trellus Health£359K1.44-£7.98M-£5.00N/A
DeepVerge£12.41M0.00-£2.46M-£0.01N/A

Summary

DeepVerge beats Trellus Health on 7 of the 10 factors compared between the two stocks.

How does Trellus Health compare to Sensyne Health?

Trellus Health (LON:TRLS) and Sensyne Health (LON:SENS) are both small-cap health information services industry companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, media sentiment, analyst recommendations, risk, dividends and valuation.

In the previous week, Trellus Health's average media sentiment score of 0.00 equaled Sensyne Health'saverage media sentiment score.

Company Overall Sentiment
Trellus Health Neutral
Sensyne Health Neutral

1.6% of Trellus Health shares are owned by institutional investors. 17.0% of Trellus Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Sensyne Health has a net margin of 0.00% compared to Trellus Health's net margin of -1,918.66%. Sensyne Health's return on equity of 0.00% beat Trellus Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Trellus Health-1,918.66% -67.29% -22.76%
Sensyne Health N/A N/A N/A

Sensyne Health has higher revenue and earnings than Trellus Health. Trellus Health is trading at a lower price-to-earnings ratio than Sensyne Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trellus Health£359K1.44-£7.98M-£5.00N/A
Sensyne Health£7.81M0.00N/A-£22.10N/A

Summary

Sensyne Health beats Trellus Health on 5 of the 8 factors compared between the two stocks.

How does Trellus Health compare to EMIS Group?

Trellus Health (LON:TRLS) and EMIS Group (LON:EMIS) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, dividends, valuation, earnings, profitability, risk, institutional ownership and media sentiment.

Trellus Health has a beta of 2.509, indicating that its share price is 151% more volatile than the broader market. Comparatively, EMIS Group has a beta of -0.13, indicating that its share price is 113% less volatile than the broader market.

1.6% of Trellus Health shares are owned by institutional investors. Comparatively, 105.6% of EMIS Group shares are owned by institutional investors. 17.0% of Trellus Health shares are owned by company insiders. Comparatively, 3.6% of EMIS Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Trellus Health's average media sentiment score of 0.00 equaled EMIS Group'saverage media sentiment score.

Company Overall Sentiment
Trellus Health Neutral
EMIS Group Neutral

EMIS Group has higher revenue and earnings than Trellus Health. Trellus Health is trading at a lower price-to-earnings ratio than EMIS Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trellus Health£359K1.44-£7.98M-£5.00N/A
EMIS Group£176.86M0.00£30.48M£0.47N/A

EMIS Group has a net margin of 17.23% compared to Trellus Health's net margin of -1,918.66%. EMIS Group's return on equity of 23.17% beat Trellus Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Trellus Health-1,918.66% -67.29% -22.76%
EMIS Group 17.23%23.17%7.99%

Summary

EMIS Group beats Trellus Health on 8 of the 10 factors compared between the two stocks.

How does Trellus Health compare to Craneware?

Trellus Health (LON:TRLS) and Craneware (LON:CRW) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, earnings, risk, analyst recommendations, valuation and dividends.

Craneware has a consensus target price of GBX 2,297.75, indicating a potential upside of 53.39%. Given Craneware's stronger consensus rating and higher probable upside, analysts clearly believe Craneware is more favorable than Trellus Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Trellus Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Craneware
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00

Craneware has higher revenue and earnings than Trellus Health. Trellus Health is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trellus Health£359K1.44-£7.98M-£5.00N/A
Craneware£211.33M2.45£14.27M£62.9023.82

In the previous week, Craneware had 2 more articles in the media than Trellus Health. MarketBeat recorded 2 mentions for Craneware and 0 mentions for Trellus Health. Trellus Health's average media sentiment score of 0.00 equaled Craneware'saverage media sentiment score.

Company Overall Sentiment
Trellus Health Neutral
Craneware Neutral

1.6% of Trellus Health shares are held by institutional investors. Comparatively, 36.8% of Craneware shares are held by institutional investors. 17.0% of Trellus Health shares are held by insiders. Comparatively, 10.2% of Craneware shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Trellus Health has a beta of 2.509, meaning that its share price is 151% more volatile than the broader market. Comparatively, Craneware has a beta of 0.28, meaning that its share price is 72% less volatile than the broader market.

Craneware has a net margin of 10.63% compared to Trellus Health's net margin of -1,918.66%. Craneware's return on equity of 6.65% beat Trellus Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Trellus Health-1,918.66% -67.29% -22.76%
Craneware 10.63%6.65%2.28%

Summary

Craneware beats Trellus Health on 13 of the 15 factors compared between the two stocks.

Get Trellus Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for TRLS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TRLS vs. The Competition

Export
MetricTrellus HealthHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£516K£332.86M£6.32B£2.79B
Dividend YieldN/A5.59%2.69%6.13%
P/E Ratio-0.02196.2321.04364.83
Price / Sales1.44129.82559.5287,614.39
Price / Cash0.7647.1442.3127.85
Price / Book0.015.569.937.83
Net Income-£7.98M-£22.78M£3.56B£5.88B
7 Day PerformanceN/A0.99%-0.44%6.72%
1 Month Performance-20.00%0.24%4.59%9.93%
1 Year Performance-88.29%-10.35%27.59%75.98%

Trellus Health Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TRLS
Trellus Health
N/AGBX 0.12
flat		N/AN/A£516K£359KN/A31
IQAI
IQ-AI
N/AGBX 0.80
flat		N/A+0.0%£1.77M£538.19KN/A6
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41MN/A73
SENS
Sensyne Health
N/AN/AN/AN/A£583K£7.81MN/A70
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:TRLS) was last updated on 6/3/2026 by MarketBeat.com Staff.
From Our Partners
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
June 12: $100 Turns Into $100,000?
The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla,...
Brownstone Research | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
Elon’s AI supercomputer just went live. Here’s my #1 stock.
Is Elon about to trigger another 315X opportunity? Elon gave Tesla investors the chance to make more than 3...
InvestorPlace | Sponsoredtc pixel